Donor and recipient age effect

Area of Science:

• Nephrology
• Transplantation Immunology

Background:

• Kidney graft survival rates have historically varied based on donor age.
• Improvements in graft survival have been observed over time, but disparities persist.
• The impact of donor age on kidney transplant outcomes requires further investigation.

Purpose of the Study:

• To analyze the influence of donor age on kidney graft survival.
• To evaluate the effect of cyclosporine on graft survival across different donor age groups.
• To compare graft survival rates between male and female donors.

Main Methods:

• Retrospective analysis of kidney transplant data.
• Comparison of graft survival rates based on donor age categories (e.g., <5, 6+, 59+).
• Assessment of cyclosporine's impact on graft survival and nonfunction rates.

Main Results:

• Kidney grafts from donors aged 6 and older showed significant survival improvement compared to those younger than 5.
• Graft survival rates from donors over 59 years old markedly increased.
• Cyclosporine use was associated with lower graft survival in older donors and a higher nonfunction rate in the first month.
• Kidneys from very young donors (<3 years) exhibited higher immunologic and technical failure rates.

Conclusions:

• Older donor kidneys, particularly those from donors over 59, demonstrate improved graft survival.
• Cyclosporine may have adverse effects on graft survival from older donors, especially within the first month post-transplant.
• Kidneys from very young donors (<3 years) are associated with poorer outcomes, even in young recipients.